Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000140

Chairperson & CEO sold 9,500 shares at an average $500.82 ($4,757,773)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-11 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-11 Sale : show line 2 in the form 10b5-1 −1,341 $496.74 $666,126 332,602 I
2026-09-11 Sale : show line 3 in the form 10b5-1 −2,138 $497.99 $1,064,700 330,464 I
2026-09-11 Sale : show line 4 in the form 10b5-1 −1,021 $498.97 $509,446 329,443 I
2026-09-11 Sale : show line 5 in the form 10b5-1 −204 $499.61 $101,921 329,239 I
2026-09-11 Sale : show line 6 in the form 10b5-1 −476 $500.86 $238,409 328,763 I
2026-09-11 Sale : show line 7 in the form 10b5-1 −1,560 $502.13 $783,323 327,203 I
2026-09-11 Sale : show line 8 in the form 10b5-1 −850 $503.10 $427,634 326,353 I
Open-market sales · 9,500 sh · avg $500.82 · $4,757,773

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-11 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option −9,500 451,910 I
Loading xslF345X06/primarydocument.xml…